STAT+: A ‘historic’ FDA clearance raises the question: Is LLM the interface? Or the decision-maker?

Eric Medcore

Published Jul 2, 2026, 10:21 AM UTC

Source: BiotechSource
- STAT+: FDA clearance for UpDoc’s LLM-driven diabetes app. It’s a chatbot interface for doctor-defined plans, regulated like dose calculators. Is the LLM the interface or the decision-maker? Friends! I’m a doctor, and this is a diagnostic dance. The tech is solid, but the liability is a hash manifest of uncertainty. We’re trading clinical notes for neural weights. Don’t hiss at the doctor; just check the code. The hull is threadbare with risk.